Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Regenerative Medicine: The Next Frontier for Big Pharma
Nov 17, 2008 12:19 PM
- 8 Stocks That Will Blow Your Minds!
Nov 12, 2008 02:23 PM
- 7 Stocks To Watch
Nov 11, 2008 02:13 PM
- StemCells Inc.: Time to Play the Election
Feb 07, 2008 01:50 AM
- Exelixis Falls on Failed Drug Study and Genentech Shares Fall on 3Q Sales
Oct 17, 2007 09:28 AM
- NASDAQ Technical Picture - Profit Taking into The Close
Sep 10, 2007 02:28 AM
- UPDATE: Stem Cell Industry Trying To See Silver Lining In Funding Stuggle
Apr 13, 2007 12:54 PM
- UPDATE: Stem Cell Industry Trying To See Silver Lining In Funding Stuggle
Apr 13, 2007 12:54 PM
- UPDATE: Stem Cell Industry Trying To See Silver Lining In Funding Stuggle
Apr 13, 2007 12:54 PM
- Aastrom' U.S. Clinical Investigator to Report on Long Bone Fracture Repair Trial and Orthovita Enters into License Agreement with Angiotech for VITAGEL(TM) Surgical Hemostat
Mar 22, 2006 02:01 PM
- Aastrom Announces Treatment of First Patient in U.S. Phase II IMPACT-DCM Trial
Nov 20, 2008 04:42 PM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: ASTM, BRCD, DPTR, GERN, SWHC, INSM
Nov 11, 2008 09:02 AM
- Aastrom Biosciences Reports First Quarter Fiscal Year 2009 Financial Results
Nov 07, 2008 02:45 PM
- Aastrom Biosciences to Present At Rodman & Renshaw 10th Annual Healthcare Conference
Nov 07, 2008 10:01 AM
- Beacon Equity Issues Technical Trade Alerts on Market Movers: ASTM, CMLS, CSUN, JASO, GERN, BRKR
Nov 04, 2008 09:01 AM
- Aastrom Announces Achievement of Milestone in U.S. Phase IIb Critical Limb Ischemia Clinical Trial
Oct 30, 2008 12:30 PM
- Aastrom Biosciences Receives Notification That NASDAQ Issued Temporary Suspension of Certain Continued Listing Requirements; Aastrom Has Until March 20, 2009 to Regain Compliance
Oct 28, 2008 03:19 PM
- Aastrom Biosciences Receives Notification That NASDAQ Issued Temporary Suspension of Certain Continued Listing Requirements
Oct 28, 2008 02:00 PM
- Aastrom Biosciences, Inc. Proxy Proposals Approved
Oct 27, 2008 03:30 PM
- Webcast Alert: Aastrom Biosciences Announces Webcast for Annual Meeting of Shareholders
Oct 13, 2008 04:16 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
ASTM
|
Compare to S&P
|
| YTD |
-28.85 %
|
16.58 %
|
| 4 Weeks |
-7.01 %
|
0.51 %
|
| 12 Weeks |
8.82 %
|
50.84 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 25.00 %
|
|
EPS Growth in Last Year: 25.00 %
|
|
Sales Growth in Last Quarter: -81.88 %
|
|
Sales Growth in Last Quarter: -68.97 %
|
|
|
